Antulos, Mercy .
HRN: 21-33-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2022
CEFUROXIME 500MG (TAB)
05/19/2022
05/26/2022
ORAL
500mg
BID
G4P4 PROM X 11h
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes